Healthcare Sep 30, 2021 02:41 PM (GMT+8) · EqualOcean
Pharmaceutical manufacturer Caelum Biosciences said that AstraZeneca would acquire all the controlling rights of Caelum Biosciences with a transaction of up to US $500 million, so as to strengthen its attention to rare disease drugs after the acquisition of alexion pharmaceuticals.